NCT06452290View on ClinicalTrials.gov

PET Biomarker Study for Antidepressant Response Prediction in Major Depressive Disorder

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 1, 2026

Primary Completion Date

September 1, 2028

Study Completion Date

March 1, 2029

Conditions
Major Depressive Disorder
Interventions
DEVICE

brain 18F-FDG PET-CT

PET scanner, Philips VEREOS PET/CT scanner. Three Philips VEREOS digital PET/CT scanners are installed in the nuclear medicine department.

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT06452290 - PET Biomarker Study for Antidepressant Response Prediction in Major Depressive Disorder | Biotech Hunter | Biotech Hunter